TREA

97681878 - MB

Follow

Information

  • Trademark
  • 97681878
  • Serial Number
    97681878
  • Filing Date
    November 17, 2022
    a year ago
  • Transaction Date
    July 30, 2024
    a month ago
  • Status Date
    July 30, 2024
    a month ago
  • Published for Opposition Date
    June 04, 2024
    3 months ago
  • Location Date
    July 30, 2024
    a month ago
  • Status Code
    688
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    TOOLEY, DAVID E
  • Attorney Docket Number
    MLB-TM000100
    Attorney Name
    Don D. Cha
    Law Office Assigned Location Code
    N70
  • Owners
Information
Mark Drawing Code
5
Mark Identification
MB
Case File Statements
  • DM0000: The mark consists of a stylized "M" to the left of a stylized "B".
  • GS0051: Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
  • PM0001: MAINLINE BIOSCIENCES
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0421: Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals
Case File Event Statements
  • 11/21/2022 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 12/8/2022 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/30/2023 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/1/2023 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/1/2023 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/1/2023 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/1/2023 - 9 months ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/22/2024 - 4 months ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 4/22/2024 - 4 months ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/22/2024 - 4 months ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/30/2024 - 4 months ago
    11 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/30/2024 - 4 months ago
    12 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/30/2024 - 4 months ago
    13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/30/2024 - 4 months ago
    14 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/30/2024 - 4 months ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/15/2024 - 3 months ago
    16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/4/2024 - 3 months ago
    17 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/4/2024 - 3 months ago
    18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/30/2024 - a month ago
    19 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM